Xu Wenshuang, Chen Qingyou, Zhang Xiaofeng, Zhao Yue, Wu Shuang, Yang Chao, Liu Yubao, Liang Lijie, Jia Di, Li Chaojun, Fan Li, Shi Yan
Department of Ophthalmology, Qiqihar Eye & ENT Hospital, Qiqihar, China.
Department of Neurology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China.
Ann Transl Med. 2022 May;10(10):587. doi: 10.21037/atm-22-2219.
To investigate the protective effect and mechanism of genipin (GE) on mitochondrial damage in retinal pigment epithelial (RPE) cells induced by high glucose.
Differential genes of GE in the treatment of diabetic retinopathy (DR) were screened by the Gene Expression Omnibus (GEO) database. Differential genes located in the pathway were obtained. TargetScan, miRDB, and DIANA databases were used to predict the targeted microRNAs (miRNAs) of differential genes. A high-fat diet combined with streptomycin (STZ) intraperitoneal injection were used to establish a diabetic mouse model. Diabetic mice were treated with GE by intragastric administration. The functional and molecular changes of the retina were detected by electroretinogram (ERG) and reverse transcription-polymerase chain reaction (RT-PCR). ARPE-19 cells were cultured under hyperglycemic conditions with and inhibitors. was knocked down/overexpressed to detect changes in cell function, activity, and mitochondrial function. The dual luciferase reporter assay confirmed the targeted binding of with
Bioinformatics analysis finally yielded as the research target gene. was predicted to be the targeted miRNA of by online databases. The results of animal experiments showed that the retinal function of mice recovered after GE administration (P<0.05), the expression of and in RPE cells was significantly increased (P<0.05), and the expression of was significantly decreased (P<0.05). The results of cell experiments showed that the functions of cells and mitochondria recovered after the addition of GE under hyperglycemia (P<0.05). Cell and mitochondrial functions were decreased after the addition of inhibitor (P<0.05). Overexpression of or inhibition of increased cell activity and mitochondrial function (P<0.05). The results of the dual luciferase reporter assay showed that had a targeted binding site with
GE protects ARPE-19 cell functional activity, inflammatory responses, and mitochondrial damage by promoting the signaling pathway and regulating the expression of the / signaling axis.
探讨京尼平(GE)对高糖诱导的视网膜色素上皮(RPE)细胞线粒体损伤的保护作用及机制。
通过基因表达综合数据库(GEO)筛选GE治疗糖尿病视网膜病变(DR)的差异基因。获得位于该通路的差异基因。利用TargetScan、miRDB和DIANA数据库预测差异基因的靶向微小RNA(miRNAs)。采用高脂饮食联合链脲佐菌素(STZ)腹腔注射建立糖尿病小鼠模型。糖尿病小鼠通过灌胃给予GE治疗。通过视网膜电图(ERG)和逆转录-聚合酶链反应(RT-PCR)检测视网膜的功能和分子变化。ARPE-19细胞在高糖条件下用和抑制剂培养。敲低/过表达以检测细胞功能、活性和线粒体功能的变化。双荧光素酶报告基因检测证实与的靶向结合。
生物信息学分析最终确定为研究靶基因。在线数据库预测为的靶向miRNA。动物实验结果表明,给予GE后小鼠视网膜功能恢复(P<0.05),RPE细胞中及的表达显著增加(P<0.05),而的表达显著降低(P<0.05)。细胞实验结果表明,高糖条件下添加GE后细胞和线粒体功能恢复(P<0.05)。添加抑制剂后细胞和线粒体功能降低(P<0.05)。过表达或抑制增加细胞活性和线粒体功能(P<0.05)。双荧光素酶报告基因检测结果表明与有靶向结合位点。
GE通过促进信号通路并调节/信号轴的表达来保护ARPE-19细胞的功能活性、炎症反应和线粒体损伤。